Feel like SE1 is entering into a critical juncture in its business - the next 3-6 months could really showcase the company’s potential or alternatively cast more doubts. Hopefully it’s the former
In the short-term, the next quarterly will tell a lot and in the more medium term, I think we need to lock away another couple of ‘anchor’ customers - can’t be too reliant on Smartbow and Abiomed.
Ann: AGM 2018 Presentation, page-69
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
